Skip to main content
. 2016 Dec 8;129(5):192–200. doi: 10.1007/s00508-016-1143-1

Fig. 6.

Fig. 6

Therapeutic intervention approach in patients with inadequate glucose control (SU sulphonylurea, DPP-4i dipeptidyl peptidase-4 inhibitor)